{"id":653581,"date":"2023-05-30T10:00:02","date_gmt":"2023-05-30T10:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=653581"},"modified":"2023-05-30T10:00:02","modified_gmt":"2023-05-30T10:00:02","slug":"burn-pain-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-states-delveinsight-cumberland-pharmaceuticals-janssen-research-development-cephalon","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/burn-pain-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-states-delveinsight-cumberland-pharmaceuticals-janssen-research-development-cephalon_653581.html","title":{"rendered":"Burn Pain Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Cumberland Pharmaceuticals, Janssen Research &#038; Development, Cephalon"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1685376940.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Burn Pain Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Cumberland Pharmaceuticals, Janssen Research &amp; Development, Cephalon\" src=\"https:\/\/www.abnewswire.com\/uploads\/1685376940.jpeg\" alt=\"Burn Pain Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Cumberland Pharmaceuticals, Janssen Research &amp; Development, Cephalon\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u201cBurn Pain Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of the Burn Pain.<\/div>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s <strong>&ldquo;Burn Pain Market Insights, Epidemiology, and Market Forecast-2032&Prime;<\/strong> report offers an in-depth understanding of the Burn Pain, historical and forecasted epidemiology as well as the Burn Pain market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To Know in detail about the Burn Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/burn-pain-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Burn Pain Market Forecast<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the Burn Pain Market Report:&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The Burn Pain market size was valued approximately <strong>USD 140 Million in 2021<\/strong> and is anticipated to grow with a significant <strong>CAGR<\/strong> during the study period <strong>(2019-2032)<\/strong><\/li>\n<li>According to DelveInsight data, there will be around <strong>2 million incident instances<\/strong> of burns requiring treatment in the 7MM in 2021, and this number is projected to rise by 2032 with a sizable CAGR<\/li>\n<li>In the 7MM, males experience more gender-specific incident cases of burns than females. There were 293,918 male cases and <strong>261,284 female cases <\/strong>in the US in 2021, respectively<\/li>\n<li>With an anticipated <strong>152,347 cases<\/strong>, Germany had the most incident cases of burns requiring pain management among the EU4 nations and the United Kingdom in 2021<\/li>\n<li><strong>Key Burn Pain Companies:<\/strong> Medical Developments International, Cumberland Pharmaceuticals, Janssen Research &amp; Development, Cephalon, and others<\/li>\n<li><strong>Key Burn Pain Therapies:<\/strong> Methoxyflurane (PENTHROX), Caldolor, JNJ-42160443, ACTIQ, and others<\/li>\n<li>The Burn Pain epidemiology based on etiology-specific cases analyzed that Etiology Specific Incident Cases of Burns is classified into Flame, Contact, Scald, Electrical, Chemical, and Others<\/li>\n<li>The Burn Pain market is expected to surge due to the disease&#8217;s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Burn Pain pipeline products will significantly revolutionize the Burn Pain market dynamics.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Burn Pain Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">An organic tissue injury known as a burn is mostly brought on by heat, radiation, radioactivity, electricity, friction, or chemical contact.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Get a Free sample for the Burn Pain Market Report &#8211;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/burn-pain-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">https:\/\/www.delveinsight.com\/sample-request\/burn-pain-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Burn Pain Epidemiology<\/strong><\/p>\n<p style=\"text-align: justify;\">The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Burn Pain Epidemiology Segmentation:<\/strong><\/p>\n<p style=\"text-align: justify;\">The Burn Pain market report proffers epidemiological analysis for the study period 2019&ndash;2032 in the 7MM segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Total Prevalence of Burn Pain<\/li>\n<li>Prevalent Cases of Burn Pain by severity<\/li>\n<li>Gender-specific Prevalence of Burn Pain<\/li>\n<li>Diagnosed Cases of Episodic and Chronic Burn Pain<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Download the report to understand which factors are driving Burn Pain epidemiology trends @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/burn-pain-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Burn Pain Epidemiology Forecast<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Burn Pain Drugs Uptake and Pipeline Development Activities<\/strong><\/p>\n<p style=\"text-align: justify;\">The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Burn Pain market or expected to get launched during the study period. The analysis covers Burn Pain market uptake by drugs, patient uptake by therapies, and sales of each drug.&nbsp;<\/p>\n<p style=\"text-align: justify;\">Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.<\/p>\n<p style=\"text-align: justify;\">The report also covers the Burn Pain Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Burn Pain Therapies and Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Methoxyflurane (PENTHROX):<\/strong> Medical Developments International<\/li>\n<li><strong>Caldolor:<\/strong> Cumberland Pharmaceuticals<\/li>\n<li><strong>JNJ-42160443:<\/strong> Janssen Research &amp; Development<\/li>\n<li><strong>ACTIQ:<\/strong> Cephalon<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Discover more about therapies set to grab major Burn Pain market share @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/burn-pain-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Burn Pain Treatment Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Burn Pain Market Strengths<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The increasing incidence of patients with burns is expected to propel the treatment market in the future, adding opportunities for new pharma players<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Burn Pain Market Opportunities<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The rising incidence of burn pain indicates increasing pharmacological treatment demands, thereby crafting lucrative opportunities for new pharma players<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Burn Pain Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Study Period: 2019&ndash;2032<\/strong><\/li>\n<li><strong>Coverage:<\/strong> 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]<\/li>\n<li><strong>Key Burn Pain Companies:<\/strong> Medical Developments International, Cumberland Pharmaceuticals, Janssen Research &amp; Development, Cephalon, and others<\/li>\n<li><strong>Key Burn Pain Therapies:<\/strong> Methoxyflurane (PENTHROX), Caldolor, JNJ-42160443, ACTIQ, and others<\/li>\n<li><strong>Burn Pain Therapeutic Assessment:<\/strong> Burn Pain current marketed and Burn Pain emerging therapies<\/li>\n<li><strong>Burn Pain Market Dynamics:<\/strong> Burn Pain market drivers and Burn Pain market barriers&nbsp;<\/li>\n<li><strong>Competitive Intelligence Analysis:<\/strong> SWOT analysis, PESTLE analysis, Porter&rsquo;s five forces, BCG Matrix, Market entry strategies<\/li>\n<li><strong>Burn Pain Unmet Needs, KOL&rsquo;s views, Analyst&rsquo;s views, Burn Pain Market Access and Reimbursement&nbsp;<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>To know more about Burn Pain companies working in the treatment market, visit @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/burn-pain-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Burn Pain Clinical Trials and Therapeutic Assessment<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Burn Pain Market Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary for Burn Pain<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis of Burn Pain<\/p>\n<p style=\"text-align: justify;\">4. Burn Pain Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Burn Pain Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Burn Pain Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Burn Pain Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Burn Pain&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Burn Pain Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Burn Pain Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Burn Pain Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Burn Pain Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Burn Pain Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Burn Pain Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Burn Pain Market Drivers<\/p>\n<p style=\"text-align: justify;\">16. Burn Pain Market Barriers<\/p>\n<p style=\"text-align: justify;\">17.&nbsp; Burn Pain Appendix<\/p>\n<p style=\"text-align: justify;\">18. Burn Pain Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p style=\"text-align: justify;\">It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_75613.html\" rel=\"nofollow\">DelveInsight Business Research<\/a><br \/><strong>Contact Person:<\/strong> Gaurav Bora<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=burn-pain-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-states-delveinsight-cumberland-pharmaceuticals-janssen-research-development-cephalon\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 8774225362<br \/><strong>Address:<\/strong>27 Drydock Ave  S. Jones Blvd #2432<br \/><strong>City:<\/strong> Boston<br \/><strong>State:<\/strong> MA<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/consulting\/asset-prioritizaton-services\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/consulting\/asset-prioritizaton-services<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/consulting\/asset-prioritizaton-services\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=burn-pain-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-states-delveinsight-cumberland-pharmaceuticals-janssen-research-development-cephalon\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight\u2019s \u201cBurn Pain Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of the Burn Pain. DelveInsight&rsquo;s &ldquo;Burn Pain Market Insights, Epidemiology, and Market Forecast-2032&Prime; report offers an in-depth understanding of the Burn Pain, historical and forecasted epidemiology &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/burn-pain-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-states-delveinsight-cumberland-pharmaceuticals-janssen-research-development-cephalon_653581.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-653581","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/653581","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=653581"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/653581\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=653581"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=653581"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=653581"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}